<DOC>
	<DOCNO>NCT00325793</DOCNO>
	<brief_summary>Hypertension ( high blood pressure ) often cause neurological worsening patient stroke , intracerebral hemorrhage subarachnoid hemorrhage . Intravenous infusion nicardipine ( Cardene ) control hypertension FDA approve . The disadvantage Nicardipine IV drip relative large volume fluid need ( 150 cc/hr ) . The purpose study evaluate safety efficacy double triple concentrate peripheral intravenous ( IV ) Nicardipine .</brief_summary>
	<brief_title>IV Double Triple Concentrated Nicardipine Stroke ICH</brief_title>
	<detailed_description>Hypertension often cause neurological worsening patient either ICH SAH . Hypertension relate increase incidence intracranial hemorrhage patient treat thrombolytic anticoagulation . Timely control hypertension directly relate outcome patient . Furthermore , unlike condition hypertensive emergency urgency , gentle titration control blood pressure recommend patient either ischemic cerebral infarction hemorrhage . Therefore ideal agent control hypertension patient would characteristic : - Rapid onset action - Predictable dose response - Titratable desired BP - Minimal dosage adjustment - Minimal adverse effect - No increase INTRACRANIAL PRESSURE ( ICP ) - Easy transition oral formulation long-term maintenance Currently , IV sodium nitroprusside , nitroglycerine , enalapril esmolol use control blood pressure patient IS , ICH SAH . These agent difficult titrate may potentially harmful brain cell . Nicardipine offer several advantage blood pressure control . It may cause dilatation coronary vessel effect cardiac conduction . It associate coronary steal . As IV calcium channel blocker approve treatment hypertension , nicardipine vasoselective , rapid onset precisely controllable variety patient type . It effective sodium nitroprusside few dose adjustment . It document safety low incidence side effect . It require minimal dose adjustment . The disadvantage Nicardipine IV drip relative large volume fluid need ( 150 cc/hr ) . In patient ischemic cerebral stroke ( IS ) hemorrhage ( ICH ) , intravenous infusion large volume contribute cerebral edema increase intracranial pressure ( ICP ) . If infusion nicardipine double triple concentrate without need central line , offer titratable BP control , also less overall volume infuse drug . This phase IV prospective , open-label , dose regimen study double triple concentration nicardipine infusion control blood pressure patient either ischemic cerebral infarction ( IS ) intracerebral hemorrhage ( ICH ) subarachnoid hemorrhage ( SAH ) . Once patient need rapid control blood pressure , eligible study . The first 25 patient consent double dose treatment next 25 patient consented triple dose treatment . The patient follow infusion period efficacy safety .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Nicardipine</mesh_term>
	<criteria>Males female , 18 year age old . Acute ischemic cerebral stroke ( IS ) uncontrollable hypertension may need control purpose consider thrombolytic therapy anticoagulation therapy . Intracerebral hemorrhagic ( ICH ) stroke patient , include subarachnoid hemorrhage ( SAH ) ( surgically treat ) , territory appropriate study ( head CT scan MRI scan ) provide result consistent diagnosis , may require control hypertension control blood pressure . Allergy Nicardipine know hypersensitivity Nicardipine . Chronic renal failure Creatinine blood sample level &gt; 2.0 . Impaired hepatic function define two time value liver enzymes . Severe leave ventricular dysfunction define ventricular ejection fraction &lt; 30 % . Patients authorize representative refuse enrol study . Advanced aortic stenosis . Pregnant nursing woman enrol study . No patient allow enrolled study . Patients may enrol clinical study involvement study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>nicardipine</keyword>
	<keyword>hypertension</keyword>
	<keyword>intracerebral hemorrhage</keyword>
	<keyword>ischemic stroke</keyword>
</DOC>